A detailed history of Abg Innovation Capital Partners Iii Gp LTD transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Abg Innovation Capital Partners Iii Gp LTD holds 26,666 shares of AADI stock, worth $76,264. This represents 4.9% of its overall portfolio holdings.

Number of Shares
26,666
Previous 26,666 -0.0%
Holding current value
$76,264
Previous $38,000 42.11%
% of portfolio
4.9%
Previous 4.54%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$25.52 - $41.85 $680,516 - $1.12 Million
26,666 New
26,666 $783,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $60.1M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Abg Innovation Capital Partners Iii Gp LTD Portfolio

Follow Abg Innovation Capital Partners Iii Gp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abg Innovation Capital Partners Iii Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Abg Innovation Capital Partners Iii Gp LTD with notifications on news.